Company Focus
Overview
Price Chart
Key Metrics
Valuation
Financials
Earnings
Dividends
Analyst Ratings
Insider Trades
Events Timeline
News + Sentiment
Peer Comparison
Nel ASA
NEL.OL Mid CapIndustrials · Specialty Industrial Machinery
Updated: May 22, 2026, 22:06 UTC
Key Metrics
Valuation Analysis
About the Company
Nel ASA, a hydrogen company, provides solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. It operates through Nel Alkaline Electrolyser and Nel PEM Electrolyser segments. The Nel Alkaline Electrolyser segment supplies hydrogen production equipment based on alkaline water electrolysis technology. The Nel PEM Electrolyser segment supplies hydrogen production equipment based on proton exchange membrane (PEM) water electrolysis technology. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.
Nel ASA Stock at a Glance
Nel ASA (NEL.OL) is currently trading at $3.58 with a market capitalization of $6.6B. The 52-week range spans from $1.92 to $3.66; the current price is 2.2% below the yearly high. Year-over-year revenue growth stands at -4.7%.
💰 Dividend
Nel ASA currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Analyst Rating
11 analysts rate Nel ASA (NEL.OL) on consensus: Underperform. The average price target is $2.12, implying -40.75% from the current price. Analyst price targets range from $1.00 to $4.20.
Investment Thesis: Strengths & Weaknesses
- High gross margin of 57.43% — indicates pricing power
- Solid balance sheet with low debt (D/E 5.97)
- –Revenue shrinking (-4.7% YoY)
- –Currently unprofitable
- –Negative free cash flow
- –Price near 52-week high — limited upside cushion
Technical Snapshot
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Risk Profile
The data points to market-like volatility.
Trading Data
Related Stocks in the Same Sector
Nel ASA 2026: Hydrogen Hangover, Cash Cliff and the IRA-EU-Subsidy Asymmetry
The Real Story
Nel ASA is the cleanest pure-play hydrogen electrolyzer name still listed, and it has been the most painful 2022-2025 hydrogen-bubble unwind. Stock collapsed from NOK 32 in 2021 to NOK 3.2 in May 2026 — a 90% wipeout. The thesis sits on two products: alkaline electrolyzers (Heroya, Norway, 1 GW/year capacity for large industrial green-hydrogen projects) and PEM electrolyzers (Wallingford, Connecticut, 500 MW/year for refueling stations and smaller distributed).
The 2022-2024 bubble priced Nel as if every announced hydrogen project would actually break ground. Reality: 78% of European announced 2030-target projects (REPowerEU 10 Mt) have been postponed, scaled back or cancelled as of Q1/2026. The US IRA 45V hydrogen production tax credit (USD 3/kg for <0.45 kgCO2e/kgH2) finally received final Treasury rules in November 2024 — but the strict additionality + temporal-matching rules excluded most early Nel-customer projects from the highest tier.
The 2025 reset was brutal but cleansing: Nel split off Cavendish/PEM-Fueling in March 2025, raised NOK 1.5 B at NOK 4.85 in October 2025, and exits Q1/2026 with NOK 850 M cash but burning NOK 350-400 M/year. The single biggest question is whether the order pipeline (USD 1.8 B identified, USD 240 M signed) converts before the cash runs out in 2027.
What Smart Money Thinks
Institutional ownership has been a graveyard. Major 2021-era holders Norges Bank Investment Management still hold 4.1% (down from 6.2%) but have been net sellers each quarter for two years. BlackRock cut from 5.4% to 1.9% over 2023-2024. The contrarian buyer is German Aquila Capital (climate-infrastructure specialist) — 3.0% disclosed in Q4/2025 at NOK 4.20-4.80, the only quality long-only fund net-buying.
Insider activity has been muted but directionally informative. CEO Hakon Volldal bought NOK 1.2 M in February 2026 at NOK 3.0-3.3 — his first open-market purchase since taking the job in 2022. CFO Kjell-Christian Bjornsen exercised 250.000 options in March and held all shares (no sales). Three board members increased stakes by aggregate NOK 4.5 M in the October 2025 rights issue.
Short interest is elevated at 11.2% of float (May 2026) — the highest in the European hydrogen complex. Most are systematic momentum shorts; the discretionary thesis-short capacity already covered after the October rights issue priced in survival.
Explore the BMI Smart-Money Tracker →
📈 The 3 Real Bull Points
The European Commission's Hydrogen Bank auctions awarded EUR 720 M in Round 1 (2024) and EUR 1.2 B in Round 2 (2025), allocating EUR 50-100/kg subsidies for 10 years to electrolyzer-backed projects. Round 3 (EUR 2.4 B, awards Q3/2026) is targeted explicitly at 100+ MW alkaline installations — Heroya's sweet spot. Nel has technical-qualifications for 6 of the 14 short-listed bidders. A 2-of-6 award rate brings ~400 MW of electrolyzer orders (USD 240-320 M) into the book.
The Treasury 45V final rules released November 2024 were strict but the December 2025 IRS guidance bulletin (Notice 2025-49) clarified that nuclear-paired and existing-clean-grid electrolyzers count under specific conditions. This unlocks USD 800 M+ of US Nel-customer projects (Plug, Air Liquide US, Iberdrola US) that were previously borderline. Nel's Wallingford PEM plant book-to-bill went from 0.4x to 1.1x in Q1/2026 — first positive print since 2022.
EU ETS Phase-IV pricing of EUR 95/ton CO2 (May 2026) plus CBAM (full enforcement 2026) make green-hydrogen-fed steel and ammonia 12-18% cheaper-per-ton vs grey-hydrogen alternatives at current natural-gas pricing. ThyssenKrupp tkH2steel Duisburg (200 MW Nel-aligned project), HBIS China (100 MW awarded Q4/2025) and Yara fertilizer (LOI 75 MW Q1/2026) are the visible signals that the demand floor is forming under the asset.
📉 The 3 Real Bear Points
Q1/2026 cash burn was NOK 92 M; FY26 burn guided NOK 350-400 M. Cash NOK 850 M at start of Q2/2026 = roughly 7-9 quarters of runway. Order conversion has been the chronic problem — average backlog-to-revenue conversion is currently 18 months (vs targeted 9). Without a major Hydrogen Bank Round 3 award by end-Q3/2026, Nel needs another rights issue in Q4/2026 — at current NOK 3.20 that means 40-50% dilution.
Sungrow, LONGi and Sinopec entered the alkaline electrolyzer market 2023-2024 at price points 55-65% below European OEMs. Q1/2026 European tenders saw average winning bid price at USD 380/kW for alkaline (vs Nel's standard USD 750-850/kW). Nel cannot match Chinese pricing without compressing gross margins below survival level. The defense is local-content rules (EU and US), but these rules are politically contested and may erode.
Green hydrogen LCOH (levelized cost of hydrogen) at EUR 4.5-6.5/kg requires electricity below EUR 30/MWh to be cost-competitive with grey hydrogen (EUR 1.5-2.5/kg at TTF gas prices). When European gas prices collapse below EUR 25/MWh (as happened H1/2026), the entire investment case for new electrolyzer capacity weakens. The market thesis only works in a structurally high gas-price world.
Valuation in Context
The forward P/E of -17.7x is meaningless — Nel will not earn money in 2026 or 2027 on consensus. The relevant lens is EV/Sales: trailing 2.4x, forward 1.9x, against European hydrogen peers ITM Power 3.1x and McPhy 2.2x. The analyst mean target NOK 2.12 (-34% downside vs current NOK 3.20) reflects bear-case consensus. The bull math requires: (a) Hydrogen Bank Round 3 award H2/2026, (b) US 45V order pickup, (c) gross-margin recovery to 20%+ by FY27. If all three hit, FY28 EV/EBITDA-positive — fair value NOK 8-12. If only one hits, fair value NOK 2.5-3.5 (no re-rating). Pure binary at the company-survival level.
🗓️ Next 3 Catalyst Dates
- Q3 2026 EU Hydrogen Bank Round 3 awards: EUR 2.4 B auction results announced — Nel has technical-qualifications for 6 of 14 bidders; 2+ award conversions add USD 240-320 M to order book
- Q4 2026 cash position update: End-of-year cash and order-book ratio determines whether 2027 rights issue is required; below NOK 500 M cash triggers dilution risk
- FY27 first profitable quarter target: Management guidance points to break-even quarter in H2/2027 — this is the binary event for re-rating; miss this and the asset is dead money
💬 Daniel's Take
Nel ASA is a true binary asymmetric bet on the European hydrogen industrial-policy thesis surviving political turnover and gas-price normalization. The downside is real — another 30-50% if a 2027 rights issue is required. The upside is also real — if Hydrogen Bank Round 3 converts and Wallingford ramps, the stock trades NOK 8-12 on relative-multiples alone. I would size this no more than 0.5-1% of equity, with the explicit understanding it can go to zero. The insider buying and Aquila long-only conviction give me some confidence the survival case is more likely than the dead-money case, but this is not a position to size up because you like green hydrogen. It is a leveraged option on a multi-year industrial-policy outcome. Stop at NOK 2.20 (under analyst mean target), no add unless the Hydrogen Bank Round 3 announcement breaks favorably.
Sources (3)
Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.
Where can I buy Nel ASA?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
